ZLAB Q4 2024 Earnings — Zai Lab Limited Revenue & Financial Results | Market Cap Arena

ZLABZai Lab Limited

$2B

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$109M+65.7% YoY

Gross Profit

$67M61.4% margin

Operating Income

-$68M-62.2% margin

Net Income

-$82M-74.9% margin

EPS (Diluted)

$-0.80

QoQ Revenue Growth

+6.7%

Cash Flow

Operating Cash Flow

-$56M

Free Cash Flow

-$74M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$345M

Stockholders' Equity

$841M

Cash & Equivalents

$450M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$109M	$66M	+65.7%
Gross Profit	$67M	$41M	+65.0%
Operating Income	-$68M	-$124M	+45.2%
Net Income	-$82M	-$95M	+14.4%

Revenue Segments

Zejula

$142M63%

Nuzyra

$33M15%

Optune

$28M12%

Qinlock

$23M10%